1. Home
  2. AGX vs MIRM Comparison

AGX vs MIRM Comparison

Compare AGX & MIRM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Argan Inc.

AGX

Argan Inc.

HOLD

Current Price

$481.00

Market Cap

6.2B

ML Signal

HOLD

Logo Mirum Pharmaceuticals Inc.

MIRM

Mirum Pharmaceuticals Inc.

HOLD

Current Price

$89.38

Market Cap

5.4B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
AGX
MIRM
Founded
1961
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Engineering & Construction
Biotechnology: Pharmaceutical Preparations
Sector
Consumer Discretionary
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.2B
5.4B
IPO Year
1995
2019

Fundamental Metrics

Financial Performance
Metric
AGX
MIRM
Price
$481.00
$89.38
Analyst Decision
Buy
Strong Buy
Analyst Count
4
12
Target Price
$321.00
$114.67
AVG Volume (30 Days)
308.3K
725.8K
Earning Date
03-26-2026
05-06-2026
Dividend Yield
0.42%
N/A
EPS Growth
157.32
74.59
EPS
6.27
N/A
Revenue
$874,179,000.00
$19,138,000.00
Revenue This Year
$8.95
$26.22
Revenue Next Year
$27.89
$21.77
P/E Ratio
$76.81
N/A
Revenue Growth
52.47
N/A
52 Week Low
$111.16
$36.88
52 Week High
$492.70
$109.28

Technical Indicators

Market Signals
Indicator
AGX
MIRM
Relative Strength Index (RSI) 61.98 43.40
Support Level $201.74 $85.76
Resistance Level N/A $107.51
Average True Range (ATR) 25.62 3.92
MACD -0.43 -0.16
Stochastic Oscillator 84.29 33.24

Price Performance

Historical Comparison
AGX
MIRM

About AGX Argan Inc.

Argan Inc is a United States-based construction firm that conducts operations through its wholly-owned subsidiaries, GPS, APC, TRC, and SMC. Through GPS and APC it provides a full range of engineering, procurement, construction, commissioning, maintenance, project development and technical consulting services to the power generation market, including the renewable energy sector, for a wide range of customers, including independent power project owners, public utilities, power plant heavy equipment suppliers and other commercial firms with power requirements in the U.S., Ireland and the U.K. It operates in three segments: Power Services, Industrial Services, and Telecom Services, out of which Power Services derives the majority of revenue.

About MIRM Mirum Pharmaceuticals Inc.

Mirum Pharmaceuticals Inc is a biopharmaceutical company focused on the identification, acquisition, development, and commercialization of novel therapies for debilitating rare and orphan diseases. Its product, Livmarli, a novel, orally administered, minimally-absorbed ileal bile acid transporter IBAT) inhibitor (IBATi), is approved for the treatment of cholestatic pruritus in patients with Alagille syndrome (ALGS). It is involved in the development of Maralixibat for the treatment of pediatric patients with progressive familial intrahepatic cholestasis, or PFIC, and Alagille syndrome, or ALGS. The company is also involved in the development of volixibat for the treatment of adult patients with cholestatic liver diseases.

Share on Social Networks: